Issue 12 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

12

December 25, 2009Dec 25, 2009

Free

DOWNLOAD THE PDF

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

Bisphosphonates May Reduce Recurrent Breast Cancer

Study Finds High-Risk Women Reluctant To Take Tamoxifen

Cervical Cancer Screening Can Be Done Later, Less Often

No Benefit For Cetuximab In Early-Stage Colon Cancer

NCI Cooperative Group Clinical Trials Approved

Recent Issues

Volume 52 | Issue 17 - May 01, 2026

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026